Edwards Lifesciences ( EW +2.7% ) news roundup: Company authorizes a new $750M buyback program and says it will complete the remainder ($140M
yield. What ails these laggards? Let's look at each of them to evaluate the prospects for a speedy recovery. Edwards Lifesciences ( EW ) (click to enlarge) EW was hammered following Complete Story »
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of ..... spinning off from Baxter International in 2000, Edwards Lifesciences has maintained its dominance in tissue heart valves
Edwards Lifesciences ( EW ) Q1 2013 Earnings Call April 23, 2013 5:00 pm ET Executives ..... a href='http://seekingalpha.com/article/1364391- edwards - lifesciences -management-discusses-q1-2013-results-earnings-call-transcript
(Reuters) - Edwards Lifesciences Corp on Tuesday lowered its 2013 outlook due to sluggish sales at the start of the year for its less-invasive replacement heart valves, and its shares plunged 15...
NEW YORK, April 23 (Reuters) - Edwards Lifesciences Corp : * Drops 14.6 percent to $70.75 in extended trade after Q1 results, outlook
April 23 (Reuters) - Edwards Lifesciences Corp said on Tuesday first-quarter net earnings more than doubled, boosted by a large gain from patent litigation with Medtronic Inc , but the heart valve maker lowered its 2013 outlook due to sluggish sales at the start of the year.
Greetings and welcome to the Edwards Lifesciences Corporation First Quarter 2013 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief
SAN FRANCISCO, March 11 (Reuters) - Patients who received the original version of Edwards Lifesciences Corp's non-invasive heart valve replacement system had a nearly identical death rate after three years as those who had open-heart
March 11 (Reuters) - Edwards Lifesciences Corp : * Death rate for Edwards lifesciences ' sapien heart valve system and